Clinical Trial Update: Phase II Umbrella Study Directed by Next Generation Sequencing [Phase 2]

View source ↗

Summary

Phase II umbrella study in non-small cell lung cancer run under next-generation sequencing guidance; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Guangdong Association of Clinical Trials | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: UNKNOWN